2nd International Conference on Immune-Mediated Diseases & 8th International Anti-Inflammation Meeting.
Braddock
Martin
M
Discovery Bioscience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, England, UK. martin.braddock@astrazeneca.com
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D004195:Disease Models, Animal; D016503:Drug Delivery Systems; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D007249:Inflammation / Q000188:drug therapy / Q000517:prevention & control*; D008396:Maryland; D051379:Mice; D013678:Technology, Pharmaceutical / Q000379:methods
D000893:Anti-Inflammatory Agents